In a study, a team of Korean researchers developed an AI model using OCT images to predict neovascular AMD treatment outcomes after anti-VEGF injections. The model highlights AI’s potential in ...

Lorati Company Limited has introduced a groundbreaking advancement in the treatment of age-related macular degeneration (AMD), including both dry and wet forms, with its nano-grade eye drops. Mr.

Eye diseases like glaucoma, cataracts, and conjunctivitis are some of the more common types. Find eye disease awareness and ...

Few pharmaceutical products have taken the market by storm like Roche’s Vabysmo. | Interim results from a late-stage trial of ...

Findings from a post hoc analysis of the AREDS and AREDS2 studies were presented at the recent American Academy of ...

Adverum Biotechnologies advances wet AMD treatment with promising trial results. See why ADVM stock has potential as it ...

The California Institute for Regenerative Medicine has funded Keck School of Medicine of USC translational research advancing ...

A retrospective review of home-based optical coherence tomography (OCT) monitoring for neovascular age-related macular ...

Opthea (ASX/NASDAQ:OPT) is a biopharmaceutical company developing novel therapies to address the unmet needs in the treatment of highly prevalent and progressive retinal diseases, including wet ...

Age-Related Macular Degeneration market growth analysis. PORTLAND, OR, UNITED STATES, November 21, 2024 /EINPresswire / -- Increase in prevalence of age-re ...

The emergent dynamics of the global Wet Age-Related Macular Degeneration (Wet AMD) pipeline offer a promising vista of therapeutic advancements, with over 70 companies and more than 75 pipeline drugs ...